NECLIFE logo

Nectar Life Sciences

(NSE: NECLIFE)

NECLIFE

22.85

0.00 (0.00%)

Nectar Life Sciences Price Chart

Note: The data used to display charts is delayed by 15 mins as per guidelines.

Nectar Life Sciences Price Chart

Note: The data used to display charts is delayed by 15 mins as per guidelines.

Nectar Life Sciences Price Summary

Today’s High

23.4

Today’s Low

22.65

52 Week's High

23.4

52 Week's Low

22.65

Nectar Life Sciences Fundamentals

Market Cap

541.6 Cr

CASA

0.0

No. Of Shares

22.4 Cr

P/E

0.0

P/B

0.4

Face Value

1.0

Dividend Yeild

0.0

Book Value

47.3

Net Interest Income

26.8

Cost to Income

NA

Promoter Holdings

55.8

EPS

-3.3

CAR

NA

ROE

-6.7

ROCE

1.4

Profit Growth

NA

Nectar Life Sciences Peer Comparison

COMPANY

PRICE

MCAP (cr)

P/B

P/E

EPS

ROE

ROCE

NII

Nectar Life Sciences

22.85

541.6 Cr

0.4

0.0

-3.3

-6.7

1.4

26.8

Artemis Medicare

61.25

569.2 Cr

1.2

41.5

5.4

2.8

5.9

183.4

Kaya

365.95

488.6 Cr

3.8

0.0

-10.8

-13.2

-1.4

44.3

Indrapras Med Corp

65.7

600.9 Cr

1.8

211.5

0.3

0.9

2.8

6.8

Windlas Biotech

231.75

481.5 Cr

0.0

0.0

7.8

2.4

5.2

19.2

Lyka Labs

132

443.7 Cr

16.9

0.0

-5.0

-124.7

4.4

139.5

FAQ’s on Nectar Life Sciences

About Nectar Life Sciences

Nectar Lifesciences (NecLife) incorporated in 1995, is a $200 million pharmaceutical organization. The company offers a range of Cephalosporin active pharmaceutical ingredients (APIs) and finished dosage forms. The company was previously known as Surya Medicare and is is promoted by Sanjiv Goyal.

NecLife is among few Indian manufacturers to develop, manufacture and market Oral and Sterile Cephalosporins and Semi Synthetic Penicillins. The company is amongst the few life saving API manufacturing companies that produces sterile APIs, through both Lyophilization and Crystallization processes.

Headquartered in Chandigarh, the company's manufacturing facilities are located at Derabassi (API and Menthol), Baddi (FDF and EHGC) and Jammu (Menthol). The company's marketing offices are situated at Delhi, Mumbai and Indore.

NecLife has received two star ‘Export House’ status from the Government of India. The company has received ISO 9001:2000 certification for quality management. The company’s manufacturing facilities for APIs were developed as per USFDA /EDQM guidelines. These facilities have also been certified by WHO GMP. The company also has a well equipped R&D unit that focuses on development of new molecules.

NecLife’s products have export presence in over 45 countries spread across 5 continents.

Products

  • NecLife manufactures and markets APIs namely Cephalothin Sodium, Cefazolin Sodium, Flucloxacillin Sodium, Oxacillin Sodium, Sulbactum Sodium, Azithromycin Dihydrate, Ceftazidime, Meropenem, Cefdinir are many others.
  • Among under finished dosage, the company manufactures products in different forms such as tablets, capsules, dry syrup and injectables (vials). It manufactures products such as Cefadroxil, Cefprozil, Cephalexin, Cefaclor and many more.
  • NecLife undertakes complete range of contract research and manufacturing services which includes formulation development, lyophilization cycle development, labelling and packaging, QC testing, stability studies and regulatory support.
  • NecLife manufactures two-piece double lock gelatin capsules under GMP standards and ISO 9002 guidelines. These capsules are BSE (Bovine spongiform encephalopathy)-free and contain no sulfites has shelf life of 5 years.
  • NecLife has also ventured into Phyto-chemicals with launch of “NECTAR MENTHOL” offering Menthol and derived products.

Future Plans

Besides India, Nectar Lifesciences plans to explore the untapped markets in regions namely Russia and CIS, China, Asia and USA.

Trade Nectar Life Sciences today

Create a free portfolio in Trinkerr and earn and grow along with peers